Clinical trial
Fosamax for Childhood Cancer Survivors
NCT00391404 · Chinese University of Hong Kong, Other · Unknown status
Key facts
| NCT number | NCT00391404 |
|---|---|
| Title | Fosamax for Childhood Cancer Survivors |
| Official title | Randomized Controlled Study on the Benefits and Safety of Bisphosphonate Treatment in Childhood Cancer Survivors |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate, Placebo |
| Enrollment | 100 |
| Start date | May 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Oct 24, 2006 |
| Last update posted | May 23, 2008 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: